Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

9.9%

77 terminated/withdrawn out of 779 trials

Success Rate

89.5%

+2.9% vs industry average

Late-Stage Pipeline

34%

261 trials in Phase 3/4

Results Transparency

60%

391 of 654 completed trials have results

Key Signals

18 recruiting391 with results48 terminated29 withdrawn

Enrollment Performance

Analytics

N/A

366(51.7%)

Phase 4

150(21.2%)

Phase 3

111(15.7%)

Phase 2

64(9.0%)

Phase 1

17(2.4%)

708Total

N/A(366)

Phase 4(150)

Phase 3(111)

Phase 2(64)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (779)

Showing 20 of 779 trials

NCT07855094Not ApplicableActive Not Recruiting

Wavelight Plus Sightmap-LASIK vs. Wavefront-Optimized-LASIK

Role: collaborator

NCT07768735Recruiting

UNITY DX Cornea Study

Role: lead

NCT07849803Phase 4Not Yet Recruiting

Effect of Acoltremon Ophthalmic Solution 0.003% on Tear Production and Symptoms in Patients With Tear Deficiency and Concurrent Neuropathic Corneal Pain

Role: collaborator

NCT07847073Phase 4Recruiting

Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients

Role: collaborator

NCT07303920Not ApplicableRecruiting

Wear Experience With Daily Disposable Contact Lenses for Astigmatism Over a Long-Wear Day

Role: collaborator

NCT04553523Not ApplicableRecruiting

Hydrus® Microstent New Enrollment Post-Approval Study

Role: lead

NCT05796453Not ApplicableCompleted

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Role: lead

NCT07147192Not ApplicableActive Not Recruiting

Feasibility Study of an Accommodating IOL Design

Role: lead

NCT07782619Recruiting

Agreement of Two OCT Biometers: A Pilot Study

Role: lead

NCT07451184Phase 4Completed

Comparison of Ocular Lubricants in People With Symptoms of Dry Eye

Role: collaborator

NCT05317728Not ApplicableActive Not Recruiting

Clinical Study of a Fluid Accommodating Intraocular Lens (IOL) Design

Role: lead

NCT07578363Phase 3Not Yet Recruiting

An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults

Role: lead

NCT05769153Phase 1Active Not Recruiting

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Role: lead

NCT07531043Phase 3Not Yet Recruiting

Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults

Role: lead

NCT07073937Enrolling By Invitation

Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty

Role: collaborator

NCT07540884Not ApplicableActive Not Recruiting

Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops

Role: lead

NCT07036835Not ApplicableCompleted

Clinical Investigation of a Femtosecond Laser for Corneal Flap Creation

Role: lead

NCT06884202Not ApplicableCompleted

Evaluation of Delefilcon A Contact Lenses

Role: lead

NCT06264830Not ApplicableCompleted

3D Visualization System in Highly Myopic Cataract Operation

Role: collaborator

NCT07243275Phase 4Completed

SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease

Role: collaborator